• Home
  • >
  • Patient Portal


Patients seeking monoclonal antibody treatment...

Notice for patients seeking monoclonal antibody treatment:

NewYork-Presbyterian, Columbia, and Weill Cornell Medicine will begin administering Sotrovimab, a monoclonal antibody treatment (mAb) effective against Omicron, only to current patients who have tested positive for COVID-19, meet eligibility requirements, and are referred by their healthcare provider.

Given the extremely limited supply of Sotrovimab, at this time we are only accepting referrals from NewYork-Presbyterian, Columbia, and Weill Cornell Medicine affiliated physicians and this medication will be limited to high risk patients who are most likely to benefit.

While our teams are working to accommodate as many patients as possible, we encourage individuals to use online resource tools, such as, to find alternative treatment sites.

Please be aware that hospital policies may change as additional information and supply becomes available. We will continue to post updates and thank you for trusting us with your care.


Patient Portal

Patient Portal: Connect

Patient Portal Login

Columbia, NewYork-Presbyterian, and Weill Cornell Medicine are leading the way to provide extraordinary care for our patients by integrating our electronic medical records.

Medical Records

To request a medical record, please visit Medical Records for more information.